[
  {
    "id": "E01",
    "title": "Disruptions in Availability of Peritoneal Dialysis and Intravenous Solutions from Baxter International Facility in North Carolina",
    "org": "US Centers for Disease Control and Prevention",
    "date": "2024-10-12",
    "period": "Event in September to October 2024",
    "location": "HAN 00518 Summary and Recommendations",
    "url": "https://www.cdc.gov/han/2024/han00518.html",
    "type": "Government health advisory",
    "claim_en": "Documents the North Cove supply interruption and potential care effects.",
    "limit_en": "Does not quantify national financial losses or prove the purchasing incentives proposed in the analysis."
  },
  {
    "id": "E02",
    "title": "FDA Roundup: October 11, 2024",
    "org": "US Food and Drug Administration",
    "date": "2024-10-11",
    "period": "2024-10-11 regulatory announcement",
    "location": "First bullet and following product list",
    "url": "https://www.fda.gov/news-events/press-announcements/fda-roundup-october-11-2024",
    "type": "Government announcement",
    "claim_en": "Identifies three additional inadequate-supply products following Helene.",
    "limit_en": "A historical shortage announcement does not establish current shortage status."
  },
  {
    "id": "E03",
    "title": "Hurricane Helene Summary",
    "org": "Baxter International",
    "date": "2025-05-13",
    "period": "September 2024 to May 2025",
    "location": "Opening statement and recovery paragraphs",
    "url": "https://www.baxter.com/news-insights/hurricane-helene-summary",
    "type": "Company first party recovery statement",
    "claim_en": "Reports flood damage, February production recovery and May inventory recovery with most IV allocations removed.",
    "limit_en": "Company-reported milestones; not an independent audit of every hospital's inventory. Production and inventory milestones are separate."
  },
  {
    "id": "E04",
    "title": "Global spending on health: Emerging from the pandemic",
    "org": "World Health Organization",
    "date": "2024-12-09",
    "period": "2022 historical baseline",
    "location": "Printed page 3 PDF page 17 Figure 1.1 and footnotes 1 and 2",
    "url": "https://www.who.int/publications/i/item/9789240104495",
    "download_url": "https://iris.who.int/server/api/core/bitstreams/6a22149b-17d5-4afb-a89b-14a3e8c12442/content",
    "type": "Official statistical report",
    "claim_en": "US$9.8 trillion current health expenditure in 2022; capital excluded. Relevant aggregates cover 190 WHO Member States.",
    "limit_en": "Historical reference, not the latest GHED observation or 2026 market size. Relevant pages were read from the downloaded original PDF. No current global growth rate is inferred."
  },
  {
    "id": "E05",
    "title": "National Health Expenditure Accounts Table 2 and NHE Fact Sheet",
    "org": "US Centers for Medicare and Medicaid Services",
    "date": "Fact sheet last modified 2026-06-24; table is the 1960 to 2024 historical release",
    "period": "Calendar 2024 United States",
    "location": "Table 2 Amount in Billions 2024 column rows 4 7 9 and 16; Fact Sheet Historical NHE 2024",
    "url": "https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/nhe-fact-sheet",
    "download_url": "https://www.cms.gov/files/zip/nhe-tables.zip",
    "type": "Official national accounts",
    "claim_en": "Total 5278.6; hospital 1634.7; physician and clinical 1109.7; retail prescription drugs 467.0, all US$bn. NHE growth 7.2%. Supports Figure 2.",
    "limit_en": "Includes investment. Retail drugs exclude medicines embedded in service spending. Residual includes all remaining NHE categories. The original workbook was downloaded and its values read, rather than using a rounded $5.3tn denominator."
  },
  {
    "id": "E06",
    "title": "2025年我国卫生健康事业发展统计公报 China Health Statistics Bulletin 2025",
    "org": "National Health Commission of China; official PDF hosted by Shanxi Health Commission",
    "date": "NHC release dated 2026-08-28; provincial PDF hosted August 2026",
    "period": "2025 China",
    "location": "Printed page 1 hospital counts; page 6 Table 4; pages 7 to 8 hospital diagnosis and treatment visits and Table 5",
    "url": "https://wjw.shanxi.gov.cn/zfxxgk/fdzdgknr/ghjh/202608/P020260831335869219767.pdf",
    "publisher_url": "https://www.nhc.gov.cn/guihuaxxs/c100132/202608/3fadb2a3da314bb688e848598f6ac6df.shtml",
    "type": "Official statistical bulletin accessed through government hosted copy",
    "claim_en": "Preliminary health expenditure and diagnosis/treatment activity; hospital counts and visits by ownership. Supports Figure 4.",
    "limit_en": "Expenditure is a preliminary estimate. Visits are encounters, not unique people. Hospital subgroups and all-institution totals have different scopes. NHC HTML could not be fully retrieved; the complete government-hosted original bulletin PDF was read."
  },
  {
    "id": "E07",
    "title": "Medicare Advantage in 2026: Enrollment Update and Key Trends",
    "org": "KFF",
    "date": "2026-06-05",
    "period": "March 2026 United States Medicare Advantage",
    "location": "Section on enrollment concentration Figure 6 and its methods note",
    "url": "https://www.kff.org/medicare/medicare-advantage-in-2026-enrollment-update-and-key-trends/",
    "type": "Original KFF analysis of CMS administrative data",
    "claim_en": "Published rounded parent-organization enrollment shares used in Figure 3.",
    "limit_en": "KFF's analysis was read; CMS microdata were not independently reaggregated. Other is a DEX residual from rounded leading shares and may differ from a raw-count aggregation. Not healthcare revenue shares."
  },
  {
    "id": "E08",
    "title": "Thermo Fisher Scientific Inc. Form 10-K for the year ended December 31, 2025",
    "org": "Thermo Fisher Scientific filing with SEC",
    "date": "2026 filing; exact filing day not relied upon",
    "period": "Year ended 2025-12-31",
    "location": "Item 1 Business Segments and Products printed pages 3 to 4",
    "url": "https://www.sec.gov/Archives/edgar/data/97745/000009774526000018/tmo-20251231.htm",
    "type": "Company regulatory filing",
    "claim_en": "Laboratory tools, clinical research, development and manufacturing services support its functional placement.",
    "limit_en": "Business descriptions are company disclosures. Corporate revenue includes non-healthcare activities; no industry share or third-party supply relationship is claimed."
  },
  {
    "id": "E09",
    "title": "Annual Report 2025 One Lonza Strategy",
    "org": "Lonza",
    "date": "2026 annual report for 2025; section undated",
    "period": "2025 with clearly identified forward plans",
    "location": "Expanding capability and capacity and Vacaville integration paragraphs",
    "url": "https://www.lonza.com/annualreport/2025/company/one-lonza-strategy",
    "type": "Company annual report",
    "claim_en": "Supports CDMO capability examples and disclosed Vacaville integration and customer agreements.",
    "limit_en": "Capabilities and selected agreements do not imply contracts with all mapped companies. Forward capacity plans are not current sales."
  },
  {
    "id": "E10",
    "title": "Eli Lilly and Company Form 10-K for the year ended December 31, 2025",
    "org": "Eli Lilly filing with SEC",
    "date": "2026-02-12",
    "period": "Year ended 2025-12-31",
    "location": "Executive Overview printed page 43; Revenue and product table page 49; Consolidated Statements of Operations",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/lly-20251231.htm",
    "type": "Company regulatory filing",
    "claim_en": "Product examples; annual income ratios; disclosed growth decomposition and product revenues for the concentration calculation.",
    "limit_en": "Company-wide annual figures, not an industry average or proof of future profitability. The DEX ratio retains the reported income definition."
  },
  {
    "id": "E11",
    "title": "Capital Markets Day 2025",
    "org": "Siemens Healthineers",
    "date": "2025-11-17",
    "period": "Strategy announced November 2025",
    "location": "Announcement bullets on Imaging Precision Therapy and Diagnostics",
    "url": "https://www.siemens-healthineers.com/press/features/cmd2025",
    "type": "Company strategy announcement",
    "claim_en": "Supports imaging diagnostics and therapy-equipment examples and announced regrouping.",
    "limit_en": "A strategy announcement does not establish realized future growth. No segment growth target is presented as an observed outcome."
  },
  {
    "id": "E12",
    "title": "Key Facts and Global Impact",
    "org": "Medtronic",
    "date": "Live page; no publication date displayed",
    "period": "Page states FY26 information",
    "location": "Three portfolios of solutions",
    "url": "https://www.medtronic.com/en-us/our-company/key-facts.html",
    "type": "Company business description",
    "claim_en": "Cardiovascular medical surgical and neuroscience portfolios support device placement.",
    "limit_en": "Self-description, not independent supplier ranking or a comprehensive therapy taxonomy."
  },
  {
    "id": "E13",
    "title": "McKesson Corporation Form 10-K for the fiscal year ended March 31, 2026",
    "org": "McKesson filing with SEC",
    "date": "2026 filing; exact filing day not relied upon",
    "period": "Fiscal year ended 2026-03-31",
    "location": "Item 1 North American Pharmaceutical; Financial Review segment operating profit margin table; Note 20",
    "url": "https://www.sec.gov/Archives/edgar/data/927653/000092765326000069/mck-20260331.htm",
    "type": "Company regulatory filing",
    "claim_en": "Distribution and logistics role; North American Pharmaceutical segment operating profit margin 1.09%.",
    "limit_en": "Fiscal period and segment operating measure differ from calendar-year group net margins. Not a whole-distribution-industry average."
  },
  {
    "id": "E14",
    "title": "HCA Healthcare Reports Fourth Quarter 2025 Results and Provides 2026 Guidance",
    "org": "HCA Healthcare",
    "date": "2026-01-27",
    "period": "Year ended 2025-12-31",
    "location": "Year ended December 31 2025 paragraph and Operating Statistics",
    "url": "https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Reports-Fourth-Quarter-2025-Results-and-Provides-2026-Guidance/default.aspx",
    "type": "Company results announcement",
    "claim_en": "Provider example; US$75600m revenue and US$6784m net income attributable to HCA.",
    "limit_en": "The ratio uses attributable net income. It is not a pure hospital segment margin or a healthcare-wide average. Forecasts in the release are not used as outcomes."
  },
  {
    "id": "E15",
    "title": "UnitedHealth Group Reports 2025 Results and Issues 2026 Outlook",
    "org": "UnitedHealth Group",
    "date": "2026-01-27",
    "period": "Year ended 2025-12-31",
    "location": "Consolidated results paragraph; site description of UnitedHealthcare and Optum",
    "url": "https://www.unitedhealthgroup.com/newsroom/2026/2026-01-27-uhg-reports-2025-results-and-issues-2026-outlook.html",
    "type": "Company results announcement",
    "claim_en": "US$447.6bn revenue and reported 2.7% net margin; insurance and services positioning.",
    "limit_en": "Consolidated group measure includes multiple businesses and financial flows. It is not an insurance-only margin or supplier market share."
  },
  {
    "id": "E16",
    "title": "Tracking universal health coverage: 2025 global monitoring report",
    "org": "World Health Organization and World Bank",
    "date": "2025-12-05",
    "period": "Service coverage 2023; financial hardship 2022",
    "location": "WHO report landing page overview",
    "url": "https://www.who.int/teams/health-financing-and-economics/global-monitoring-report/2025",
    "type": "Official monitoring summary",
    "claim_en": "4.6bn not fully covered and 2.1bn experiencing financial hardship, with distinct data years.",
    "limit_en": "Estimates use revised indicators; groups overlap and cannot be added. Landing-page summary was read, not the entire monitoring report."
  },
  {
    "id": "E17",
    "title": "Health workforce",
    "org": "World Health Organization",
    "date": "Live topic page; publication day not displayed",
    "period": "Projection for 2030",
    "location": "Overview first paragraphs",
    "url": "https://www.who.int/health-topics/health-workforce",
    "type": "Official workforce assessment",
    "claim_en": "Projected 11m health-worker shortfall and explanation of financing and distribution constraints.",
    "limit_en": "Projection rather than an observed current shortage; primarily low- and lower-middle-income settings. Not doctors alone."
  },
  {
    "id": "E18",
    "title": "Ageing and health",
    "org": "World Health Organization",
    "date": "2025-10-01",
    "period": "Projection for 2030",
    "location": "Overview population paragraph",
    "url": "https://www.who.int/news-room/fact-sheets/detail/ageing-and-health",
    "type": "Official demographic fact sheet",
    "claim_en": "One in six globally aged 60 years or older by 2030.",
    "limit_en": "Demographic projection is not a commercial market forecast and does not imply uniform care needs."
  },
  {
    "id": "E19",
    "title": "DRG DIP 2.0 policy explanation July 2024",
    "org": "National Healthcare Security Administration of China",
    "date": "2024-07-23",
    "period": "Historical 2024 policy example",
    "location": "Section on main contents and exceptional case review",
    "url": "https://www.nhsa.gov.cn/art/2024/7/23/art_105_13316.html",
    "type": "Official policy explanation",
    "claim_en": "Explains grouping reform and exceptional-case review relevant to payment incentives.",
    "limit_en": "Used only as a dated mechanism example; not represented as the latest applicable grouping. Local rules and later revisions require separate review."
  },
  {
    "id": "E20",
    "title": "List of Artificial Intelligence-Enabled Medical Devices",
    "org": "US Food and Drug Administration",
    "date": "Live list read 2026-10-26",
    "period": "Authorizations identified in the current published list",
    "location": "Contents of the AI Enabled Medical Devices List",
    "url": "https://www.fda.gov/medical-devices/artificial-intelligence-enabled-medical-devices/list-artificial-intelligence-enabled-medical-devices",
    "type": "Regulator maintained device list and methods",
    "claim_en": "List purpose and explicit non-comprehensive limitation.",
    "limit_en": "Does not report deployment revenue reimbursement or general superiority. No device count is used as a market size."
  },
  {
    "id": "E21",
    "title": "Considerations for the Regulation of Generative AI-Enabled Medical Devices: Discussion Paper and Request for Feedback",
    "org": "US Food and Drug Administration",
    "date": "2026; exact release day not relied upon",
    "period": "2026 discussion paper",
    "location": "About the Discussion Paper status paragraphs",
    "url": "https://www.fda.gov/medical-devices/digital-health-center-excellence/considerations-regulation-generative-ai-enabled-medical-devices-discussion-paper-and-request",
    "type": "Regulator discussion document landing page",
    "claim_en": "Topics include risk premarket evaluation and monitoring; explicitly neither draft nor final guidance.",
    "limit_en": "Not a new binding rule or a general authorization. The page was read; the full discussion PDF was not independently reviewed."
  },
  {
    "id": "E22",
    "title": "Parts of Medicare",
    "org": "US Centers for Medicare and Medicaid Services Medicare.gov",
    "date": "Live public information page; no publication day displayed",
    "period": "Definition read on 2026-10-26",
    "location": "Your Medicare options and Medicare Advantage also known as Part C",
    "url": "https://www.medicare.gov/basics/get-started-with-medicare/medicare-basics/parts-of-medicare",
    "type": "Official program explanation",
    "claim_en": "Defines Medicare Advantage and distinguishes it from Original Medicare.",
    "limit_en": "Program explanation, not enrollment shares, revenue or a recommendation to select a plan."
  },
  {
    "id": "E23",
    "title": "国家医保局按病种付费3.0版分组方案新闻发布会实录 Official press conference on DRG DIP version 3.0",
    "org": "National Healthcare Security Administration of China",
    "date": "2026-09-02",
    "period": "September 2026 policy announcement and mechanism explanation",
    "location": "Opening announcement; answer on payment standards and retention of savings; exceptional-case review",
    "url": "https://www.nhsa.gov.cn/art/2026/9/2/art_14_21978.html",
    "type": "Official press conference transcript",
    "claim_en": "Version 3.0 announcement and explanation of group-based standards, savings and treatment of individual cases.",
    "limit_en": "The original HTML was downloaded and read because web text retrieval timed out. The transcript does not substitute for local payment schedules or the signed contract; no implementation deadline is asserted here."
  }
]
